# Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy

> **NCT04380064** · NA · UNKNOWN · sponsor: **Rush Eye Associates** · enrollment: 200 (estimated)

## Conditions studied

- Diabetic Retinopathy Visually Threatening

## Interventions

- **PROCEDURE:** ILM Peeling
- **PROCEDURE:** No ILM Peeling

## Key facts

- **NCT ID:** NCT04380064
- **Lead sponsor:** Rush Eye Associates
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-01
- **Primary completion:** 2025-02-01
- **Final completion:** 2025-02-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04380064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04380064, "Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04380064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*